These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 38999758)

  • 1. Exploring the Regulatory Effect of LPJZ-658 on Copper Deficiency Combined with Sugar-Induced MASLD in Middle-Aged Mice Based on Multi-Omics Analysis.
    Li C; Liu Z; Wei W; Chen C; Zhang L; Wang Y; Zhou B; Liu L; Li X; Zhao C
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999758
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Liu L; Deng L; Wei W; Li C; Lu Y; Bai J; Li L; Zhang H; Jin N; Li C; Zhao C
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics and multiomics reveal Liupao tea extract alleviating NAFLD via regulating hepatic lipid metabolism and gut microbiota.
    Yang S; Wei Z; Luo J; Wang X; Chen G; Guan X; She Z; Liu W; Tong Y; Liu H; Wen M; Chen H; Zhu P; Li G; Wang D; Huang L; Xu S; Chen D; Zhang Q; Wei Y
    Phytomedicine; 2024 Sep; 132():155834. PubMed ID: 38941818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilostazol Attenuates Hepatic Steatosis and Intestinal Disorders in Nonalcoholic Fatty Liver Disease.
    Min T; Qiu S; Bai Y; Cao H; Guo J; Su Z
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model.
    Iannone V; Babu AF; Lok J; Gómez-Gallego C; D'Auria G; Vazquez-Uribe R; Vaaben TH; Bongers M; Mikkonen S; Vaittinen M; Tikkanen I; Kettunen M; Klåvus A; Sehgal R; Kaminska D; Pihlajamaki J; Hanhineva K; El-Nezami H; Sommer MOA; Kolehmainen M
    Mol Metab; 2023 Dec; 78():101823. PubMed ID: 37839774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective mechanism of Lactobacillus plantarum FZU3013 against non-alcoholic fatty liver associated with hyperlipidemia in mice fed a high-fat diet.
    Chen M; Guo WL; Li QY; Xu JX; Cao YJ; Liu B; Yu XD; Rao PF; Ni L; Lv XC
    Food Funct; 2020 Apr; 11(4):3316-3331. PubMed ID: 32226996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics.
    Yuan H; Jung ES; Chae SW; Jung SJ; Daily JW; Park S
    Nutrients; 2024 Sep; 16(18):. PubMed ID: 39339660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Regulatory Effect of Tegillarca granosa Polysaccharide on High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice Based on Intestinal Flora.
    Yang X; Yao S; Jiang Q; Chen H; Liu S; Shen G; Xiang X; Chen L
    Mol Nutr Food Res; 2024 Jul; 68(14):e2300453. PubMed ID: 38389187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupeol improves bile acid metabolism and metabolic dysfunction-associated steatotic liver disease in mice via FXR signaling pathway and gut-liver axis.
    Qin D; Pan P; Lyu B; Chen W; Gao Y
    Biomed Pharmacother; 2024 Aug; 177():116942. PubMed ID: 38889641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of apolipoprotein H downregulation on lipid metabolism, fatty liver disease, and gut microbiota dysbiosis.
    Liu Y; Zhao Y; Liu Q; Li B; Daniel PV; Chen B; Wu Z
    J Lipid Res; 2024 Jan; 65(1):100483. PubMed ID: 38101620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Hesperidin Supplementation on Liver Metabolomics and Gut Microbiota in a High-Fat Diet-Induced NAFLD Mice Model.
    Li X; Yao Y; Wang Y; Hua L; Wu M; Chen F; Deng ZY; Luo T
    J Agric Food Chem; 2022 Sep; 70(36):11224-11235. PubMed ID: 36048007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses.
    Wang S; Li X; Zhang B; Li Y; Chen K; Qi H; Gao M; Rong J; Liu L; Wan Y; Dong X; Yan M; Ma L; Li P; Zhao T
    Biomed Pharmacother; 2024 Apr; 173():116405. PubMed ID: 38484559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
    Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
    J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common Bean Suppresses Hepatic Ceramide Metabolism in a Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Fitzgerald VK; Lutsiv T; McGinley JN; Neil ES; Playdon MC; Thompson HJ
    Nutrients; 2024 Sep; 16(18):. PubMed ID: 39339796
    [No Abstract]   [Full Text] [Related]  

  • 15. Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy.
    Qiu J; Chen L; Zhang L; Xu F; Zhang C; Ren G; Chang K; He G; Du Z; Le Y; Yu Z; Li S; Liu Q; Dou X
    Phytomedicine; 2023 Dec; 121():155111. PubMed ID: 37804819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel fatty acid mimetic with pan-PPAR partial agonist activity inhibits diet-induced obesity and metabolic dysfunction-associated steatotic liver disease.
    Sahin C; Melanson JR; Le Billan F; Magomedova L; Ferreira TAM; Oliveira AS; Pollock-Tahari E; Saikali MF; Cash SB; Woo M; Romeiro LAS; Cummins CL
    Mol Metab; 2024 Jul; 85():101958. PubMed ID: 38763495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori infection exacerbates metabolic dysfunction-associated steatotic liver disease through lipid metabolic pathways: a transcriptomic study.
    Chen X; Peng R; Peng D; Liu D; Li R
    J Transl Med; 2024 Jul; 22(1):701. PubMed ID: 39075482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Lipidomics and Metabolomics Reveal the Underlying Mechanisms of Taurine in the Alleviation of Nonalcoholic Fatty Liver Disease Using the Aged Laying Hen Model.
    Yu Z; Cheng M; Luo S; Wei J; Song T; Gong Y; Zhou Z
    Mol Nutr Food Res; 2023 Dec; 67(24):e2200525. PubMed ID: 37909476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotic Mixture Ameliorates a Diet-Induced MASLD/MASH Murine Model through the Regulation of Hepatic Lipid Metabolism and the Gut Microbiome.
    Zhang F; Lo EKK; Chen J; Wang K; Felicianna ; Ismaiah MJ; Leung HKM; Zhao D; Lee JC; El-Nezami H
    J Agric Food Chem; 2024 Apr; 72(15):8536-8549. PubMed ID: 38575146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganoderic acid A from Ganoderma lucidum ameliorates lipid metabolism and alters gut microbiota composition in hyperlipidemic mice fed a high-fat diet.
    Guo WL; Guo JB; Liu BY; Lu JQ; Chen M; Liu B; Bai WD; Rao PF; Ni L; Lv XC
    Food Funct; 2020 Aug; 11(8):6818-6833. PubMed ID: 32686808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.